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Dr Vouyouka and colleagues are to be commended for their
important contribution to the literature entitled: “Lessons learned
outcomes of lower extremity peripheral arterial disease”. The
influence of gender on peripheral arterial disease (PAD) is not well
studied and is not well defined in the current literature. Unfortu-
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Volume 52, Number 5 Bush 1203nately, women have been excluded from clinical trials due to the
confounding factors such as hormonal influences, andDrVouyouka’s
analysis of a large administrative data set emphasizes gender-
related disparities that exist in the care of patients with atheroscle-
rotic vascular disease. This is truly a tragedy, as it is well known that
PAD is a surrogate marker for systemic vascular disease. Besides
having an elevated risk of severe atherothrombotic vascular events
such as stroke, heart disease, and limb loss, patients with PAD also
experience a resultant decrease in quality of life and increased
cardiovascular morbidity and mortality.1-3 Despite the magnitude
of this health problem, screening and treatment rates in high-risk
populations are inappropriately low, particularly for women. Ag-
gressive screening programs to detect atherosclerosis have been
advocated as well as aggressive risk factor management in women
with asymptomatic disease.4 Primary prevention measures can be
instituted once an estimate of absolute cardiovascular risk is
known.
Furthermore, as Dr Vouyouka indicates in the discussion
section, many health care providers do not address cardiovascular
disease or risk factors with their female patients, and sometimes are
not aware of gender differences in symptoms, symptom reporting,
and differing patient beliefs and attitudes. The authors clearly
conclude from this data analysis that “aggressive modification of
risk factors . . . may improve gender-related disparity in the out-
comes of vascular disease”. However, in order for this to take place,the risk factor must be recognized through thorough history
taking or evaluation. The burden is upon the medical profession to
identify women and men prior to the onset of symptoms or
limb-threatening disease, or even the onset of coronary or cerebro-
vascular symptoms. We must recognize women as having equiva-
lent risks of atherosclerotic disease as men and proceed with testing
women to avoid misdiagnosis. We also need to identify societal
obstacles that promote isolation and prevent women from seeking
evaluation and work to circumvent these obstacles. This article is
an important one that should be read by physicians of numerous
specialties.
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